Innate Pharma S.A.

IPHA | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.82

-$0.04 (-2.15%)

Sep 22, 2026, 1:47 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

TTM Period Ending	Q2 2026 Jun 29, 2026	Q4 2025 Dec 30, 2025	Q2 2025 Jun 29, 2025	Q4 2024 Dec 30, 2024	Q2 2024 Jun 29, 2024	Q4 2023 Dec 30, 2023	Q2 2023 Jun 29, 2023	Q4 2022 Dec 30, 2022	Q2 2022 Jun 29, 2022	Q4 2021 Dec 30, 2021	Q2 2021 Jun 29, 2021
Cash & Equivalents	6.46M	28.08M	53.7M	66.4M	69.99M	70.61M	71.41M	84.23M	102.95M	103.76M	103.98M
Short-Term Investments	4.43M	6.22M	6.32M	14.37M	21.81M	21.85M	17.48M	17.26M	20.4M	16.08M	15.34M
Long-Term Investments	10.48M	10.7M	10.39M	10.28M	10.35M	9.8M	35.79M	35.12M	34.81M	39.88M	40.08M
Other Long-Term Assets	1M	946.6K	12.61M	9.9M	14.56M	1.64M	965K	14.25M	13.24M	29.97M	34.96M
Receivables	4.58M	7.61M	1.2M	1.64M	13.83M	46.49M	2.93M	3.14M	41.83M	1.66M	3.6M
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	4.12M	-4.28K	2K	n/a	1K	n/a	49.3M	27.88M	n/a	11.81M	n/a
Total Current Assets	19.59M	46.69M	64.98M	85.74M	111.59M	148.01M	144.46M	139.83M	171.8M	138.26M	129.69M
Property-Plant & Equipment	3.64M	4.35M	4.96M	5.13M	5.75M	6.32M	7.26M	8.54M	9.56M	10.17M	10.89M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	119K	416K	903K	1.56M	43.25M	44.19M	45.19M
Total Long-Term Assets	15.12M	16M	27.96M	25.32M	39.9M	27.18M	54.59M	68.03M	108.63M	129.24M	136.53M
Total Assets	34.71M	62.69M	92.94M	111.06M	151.5M	175.19M	199.05M	207.86M	280.43M	267.5M	266.22M
Account Payables	5.43M	15.04M	4.55M	7.92M	8.75M	8.56M	9.87M	13.66M	12.92M	14.73M	11.18M
Deferred Revenue	n/a	2.82M	563K	616K	2.8M	5.87M	5.05M	6.56M	9.09M	12.5M	10.46M
Short-Term Debt	10.79M	8.52M	8.47M	8.44M	8.51M	8.45M	5.34M	1.26M	30.85M	29.94M	2.02M
Other Current Liabilities	16.63M	9.97M	7.89M	7.65M	20.54M	7.82M	17.41M	19.02M	20.69M	21.91M	18.96M
Total Current Liabilities	32.84M	36.63M	29.43M	32.98M	38.22M	39.64M	37.67M	41.34M	73.56M	79.89M	42.62M
Long-Term Debt	9.37M	13.67M	17.93M	22.18M	26.41M	30.61M	35.32M	38.93M	12.52M	11.49M	14.49M
Other Long-Term Liabilities	32.95M	33.99M	37.64M	44.13M	57.9M	39.07M	52.55M	55.74M	61.9M	36.23M	42.55M
Total Long-Term Liabilities	42.36M	47.75M	58.37M	69.24M	84.48M	83.65M	103.52M	112.37M	90.54M	80.17M	90.04M
Total Liabilities	75.2M	84.39M	87.79M	102.23M	122.7M	123.29M	141.19M	153.71M	164.1M	160.06M	132.66M
Total Debt	10.83M	22.56M	27.03M	31M	35.5M	39.89M	40.66M	42.25M	43.37M	44.25M	16.5M
Book Value	-40.49M	-21.69M	5.14M	8.83M	28.8M	51.9M	57.86M	54.15M	116.33M	107.44M	133.56M
Book Value Per Share	-0.43	-0.24	0.06	0.11	0.36	0.64	0.69	0.68	1.42	1.35	1.69
Common Stock	4.7M	4.69M	4.61M	4.19M	4.05M	4.04M	4.03M	4.01M	3.99M	3.98M	3.95M
Retained Earnings	-454.98M	-435.36M	-407.71M	-386.36M	-361.66M	-336.89M	-328.6M	-330.32M	-265.94M	-272.21M	-244.15M
Comprehensive Income	864.64K	1.12M	1.19M	27K	355K	495K	1.06M	819K	284K	456K	715K
Shareholders Equity	-40.49M	-21.69M	5.14M	8.83M	28.8M	51.9M	57.86M	54.15M	116.33M	107.44M	133.56M
Total Investments	14.91M	16.92M	16.71M	24.66M	32.16M	31.65M	53.27M	52.38M	55.21M	55.96M	55.42M